MARIO VALENZUELA: Open Payments
NPI 1255436705 · PORTAGE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 35 payments from 6 companies in 2025. Trend: 2023 $358 · 2024 $821 · 2025 $647
Food & beverage: $643Education: $4
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $207 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| ABBVIE INC. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
Products named: CAPLYTA, LYBALVI, ARISTADA, INGREZZA, VRAYLAR, COBENFY, REXULTI, ABILIFY ASIMTUFII.
Industry payments across WI — which companies pay providers there.
